Sanofi Consumer Healthcare India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2025 ,inter alia, to consider and approve the Unaudited ....
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India Ltd has informed the stock exchanges that its Board of Directors will meet on Friday, 2nd May 2025. The key agenda is to consider and approve the Unaudited Financial Results for the quarter ended 31st March 2025 (Q4 FY25). The intimation has been filed with both BSE (Scrip Code: 544250) and NSE (Symbol: SANOFICONR) under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements. The trading window for designated persons remains closed from 1st April 2025 to 4th May 2025, in line with the company's insider trading code. No actual financial numbers have been disclosed in this filing — it is purely a procedural notice ahead of the results announcement.
This is a routine compliance filing and contains no financial data or surprises. Investors should await the Q4 FY25 unaudited results to be published on or after 2nd May 2025 to gauge the company's quarterly performance.